TY - JOUR
T1 - Anterior Uveitis following COVID Vaccination
T2 - A Summary of Cases from Global Reporting Systems
AU - Nanji, Afshan A.
AU - Fraunfelder, Frederick T.
N1 - Publisher Copyright:
© 2022 Taylor & Francis Group, LLC.
PY - 2022
Y1 - 2022
N2 - Purpose: COVID-19 vaccines are currently undergoing long-term safety monitoring, including for ocular side effects. Uveitis following vaccination has been described previously with other vaccines and warrants evaluation for COVID-19 vaccines, especially given their widespread use. Case Reports: We present two cases of patients who developed anterior uveitis following the Moderna COVID-19 vaccine, as reported to the National Registry for Drug-Induced Ocular Side Effects. We also summarize reports of anterior uveitis following COVID-19 vaccination as reported to the World Health Organization global database of individual case safety reports. Conclusions: Based on the temporal pattern of ocular inflammation following vaccine delivery in these cases, an association may be present between uveitis and COVID-19 vaccination. Further investigation to explore this association is warranted to guide patient care.
AB - Purpose: COVID-19 vaccines are currently undergoing long-term safety monitoring, including for ocular side effects. Uveitis following vaccination has been described previously with other vaccines and warrants evaluation for COVID-19 vaccines, especially given their widespread use. Case Reports: We present two cases of patients who developed anterior uveitis following the Moderna COVID-19 vaccine, as reported to the National Registry for Drug-Induced Ocular Side Effects. We also summarize reports of anterior uveitis following COVID-19 vaccination as reported to the World Health Organization global database of individual case safety reports. Conclusions: Based on the temporal pattern of ocular inflammation following vaccine delivery in these cases, an association may be present between uveitis and COVID-19 vaccination. Further investigation to explore this association is warranted to guide patient care.
KW - COVID-19
KW - National Registry of Drug-Induced Ocular Side Effects
KW - Uppsala Monitoring Center
KW - anterior uveitis
KW - vaccine
UR - http://www.scopus.com/inward/record.url?scp=85125889338&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125889338&partnerID=8YFLogxK
U2 - 10.1080/09273948.2022.2042316
DO - 10.1080/09273948.2022.2042316
M3 - Letter
C2 - 35226563
AN - SCOPUS:85125889338
SN - 0927-3948
VL - 30
SP - 1244
EP - 1246
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 5
ER -